| Other cytostatics |
All Financial Data in US $ (mln) |
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.
|
| EvaluatePharma® Coverage of Marketed and Pipeline Products |
|
|
Product Count
|
| Other cytostatics1 |
2,770 |
|
| Therapy Area Worldwide Sales (2007/08) |
|
Annual Sales WW - Sales
|
Growth per Year (%)
|
|
Rank2 |
Company
|
Product
|
2007 |
2008
|
2008 |
| Other cytostatics3 |
|
|
|
6,838 |
9,255 |
|
+35% |
|
|
Note: Shaded Cells4 |
|
|
| Product Worldwide Market Share 2008 |
|
|
| Top 3 Marketed Products by Therapy Area in 2008 |
|
|
|
Register to access more FREE content:
- Top 5 Products Worldwide Sales 2009
- Top 5 Products Market Share 2009
- Download to Excel
- Search 2 yrs of company press releases
|
|
|
|